Does hypercoagulopathy testing benefit patients with DVT?

dc.contributor.author	Saultz, Alisha	eng
dc.contributor.author	Mathews, Erin Lindsay	eng
dc.contributor.author	Saultz, John W.	eng
dc.date.issued	2010	eng
dc.description.abstract	There is no evidence to suggest that testing for hypercoagulopathy benefits most patients with deep venous thrombosis (DVT). Nor has research established that thrombophilia test results improve the ability to predict recurrence better than clinical risk assessment alone (strength of recommendation [SOR]: B, multiple cohort studies).	eng
dc.identifier.uri	http://hdl.handle.net/10355/7717	eng
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Clinical Inquiries, 2010 (MU)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 59, no. 05 (May 2010): 291+.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	thromboembolism	eng
dc.subject	recurrence risk	eng
dc.subject.lcsh	Anticoagulants (Medicine)	eng
dc.subject.lcsh	Thromboembolism -- Treatment	eng
dc.subject.lcsh	Warfarin	eng
dc.title	Does hypercoagulopathy testing benefit patients with DVT?	eng
dc.type	Article	eng

Clinical Inquiries, 2010
The items in this collection constitute volume 59 of Clinical Inquiries.